|
FY2026
12 months to Jun 30, 2026
|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales, general and administrative | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Interest expense and other, net | |||||
| Income before income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Net income per share of common stock: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares used in computing net income per share of common stock: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Other comprehensive income: | |||||
| Unrealized (losses) gains on available-for-sale investments | |||||
| Other comprehensive (loss) income | |||||
| Comprehensive income |
Loading...
